List of works - Wei Wang

A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors

scientific article published on 08 March 2007

Anti-lung cancer effects of novel ginsenoside 25-OCH(3)-PPD.

scientific article

Antisense approaches in drug discovery and development.

scientific article

Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9

scientific article published on 01 June 2006

Experimental Therapy of Ovarian Cancer with Synthetic Makaluvamine Analog: In Vitro and In Vivo Anticancer Activity and Molecular Mechanisms of Action ⬇️

scientific article published on June 6, 2011

Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53.

scientific article published on June 2007

Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy

scientific article published on November 2006

Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides

scientific article

Ginsenosides as anticancer agents: In vitro and in vivo activities, structure–activity relationships, and molecular mechanisms of action ⬇️

scientific article published on February 28, 2012

Identification of a new class of MDM2 inhibitor that inhibits growth of orthotopic pancreatic tumors in mice

scientific article

Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.

scientific article published on February 2015

Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.

scientific article published on July 2013

Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy

scientific article published on 01 August 2006

In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng

scientific article published on 22 August 2006

Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA

scientific article published on 8 October 2015

JKA97, a novel benzylidene analog of harmine, exerts anti-cancer effects by inducing G1 arrest, apoptosis, and p53-independent up-regulation of p21

scientific article

KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology

scientific article

NFAT as cancer target: mission possible?

scientific article

Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2.

scientific article

Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine

Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action

scientific article

Pharmacokinetics and tissue distribution of 25-hydroxyprotopanaxadiol, an anti-cancer compound isolated from Panax ginseng, in athymic mice bearing xenografts of human pancreatic tumors ⬇️

scientific article published on December 28, 2010

Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis

scientific article published on September 2006

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications

scientific article

The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models

scientific article published on 01 October 2014

Transcription Factor NFAT1 Activates the mdm2 Oncogene Independent of p53 ⬇️

scientific article published on July 11, 2012

List of works by Wei Wang

A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors

Anti-lung cancer effects of novel ginsenoside 25-OCH(3)-PPD.

Antisense approaches in drug discovery and development.

Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9

Experimental Therapy of Ovarian Cancer with Synthetic Makaluvamine Analog: In Vitro and In Vivo Anticancer Activity and Molecular Mechanisms of Action ⬇️

Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53.

Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy

Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides

Ginsenosides as anticancer agents: In vitro and in vivo activities, structure–activity relationships, and molecular mechanisms of action ⬇️

Identification of a new class of MDM2 inhibitor that inhibits growth of orthotopic pancreatic tumors in mice

Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.

Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.

Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy

In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng

Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA

JKA97, a novel benzylidene analog of harmine, exerts anti-cancer effects by inducing G1 arrest, apoptosis, and p53-independent up-regulation of p21

KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology

NFAT as cancer target: mission possible?

Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2.

Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine

Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action

Pharmacokinetics and tissue distribution of 25-hydroxyprotopanaxadiol, an anti-cancer compound isolated from Panax ginseng, in athymic mice bearing xenografts of human pancreatic tumors ⬇️

Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications

The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models

Transcription Factor NFAT1 Activates the mdm2 Oncogene Independent of p53 ⬇️